Clinical Focus ›› 2021, Vol. 36 ›› Issue (5): 446-452.doi: 10.3969/j.issn.1004-583X.2021.05.012
Previous Articles Next Articles
Xu Jianfa1a, Tan Zirui1b, Li Jie1c, Wang Miao1b, Wang Guiying2()
Received:
2020-10-26
Online:
2021-05-20
Published:
2021-06-09
CLC Number:
Xu Jianfa, Tan Zirui, Li Jie, Wang Miao, Wang Guiying. Construction and analysis of forecast nomogram on prognostic patients with bone metastases from rectal cancer[J]. Clinical Focus, 2021, 36(5): 446-452.
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.05.012
临床病理资料 | 建模组 | 验证组 |
---|---|---|
性别 | ||
男 | 439(65.42) | 77(71.30) |
女 | 232(34.58) | 31(28.70) |
年龄 | ||
<66岁 | 289(43.07) | 45(41.67) |
≥66~75岁 | 293(43.67) | 54(54.00) |
>75岁 | 89(13.26) | 9(8.33) |
种族 | ||
白 | 523(77.94) | 83(76.85) |
黑 | 85(12.67) | 12(11.11) |
其他 | 63(9.39) | 13(12.04) |
组织学分级 | ||
Ⅰ/Ⅱ | 318(47.39) | 46(42.59) |
Ⅲ/Ⅳ | 166(24.74) | 31(28.70) |
未知 | 187(27.87) | 31(28.70) |
T分期 | ||
T0 | 2(0.30) | 1(0.93) |
T1 | 92(13.71) | 12(11.11) |
T2 | 27(4.02) | 5(4.63) |
T3 | 166(24.74) | 28(25.93) |
T4 | 136(20.27) | 23(21.30) |
Tx | 248(36.96) | 39(36.11) |
N分期 | ||
N0 | 237(35.32) | 33(30.56) |
N1 | 243(36.21) | 38(35.19) |
N2 | 83(12.37) | 18(16.67) |
Nx | 108(16.10) | 19(17.59) |
M分期 | ||
M1a | 89(13.26) | 19(17.59) |
M1b | 521(77.65) | 79(73.15) |
M1x | 61(9.09) | 10(9.26) |
手术情况 | ||
否 | 546(81.37) | 88(81.48) |
是 | 125(18.63) | 20(18.52) |
淋巴结转移情况 | ||
否 | 576(85.84) | 92(85.19) |
是 | 95(14.16) | 16(14.81) |
脑转移情况 | ||
否 | 646(96.27) | 105(97.22) |
是 | 25(3.73) | 3(2.78) |
肝转移情况 | ||
否 | 239(35.62) | 38(35.19) |
是 | 432(64.38) | 70(64.81) |
肺转移情况 | ||
否 | 381(56.78) | 67(62.04) |
是 | 290(43.22) | 41(37.96) |
放疗情况 | ||
否 | 599(89.27) | 98(90.74) |
是 | 72(10.73) | 10(9.26) |
化疗情况 | ||
否 | 179(26.68) | 23(21.30) |
是 | 492(73.32) | 85(78.70) |
临床病理资料 | 建模组 | 验证组 |
---|---|---|
性别 | ||
男 | 439(65.42) | 77(71.30) |
女 | 232(34.58) | 31(28.70) |
年龄 | ||
<66岁 | 289(43.07) | 45(41.67) |
≥66~75岁 | 293(43.67) | 54(54.00) |
>75岁 | 89(13.26) | 9(8.33) |
种族 | ||
白 | 523(77.94) | 83(76.85) |
黑 | 85(12.67) | 12(11.11) |
其他 | 63(9.39) | 13(12.04) |
组织学分级 | ||
Ⅰ/Ⅱ | 318(47.39) | 46(42.59) |
Ⅲ/Ⅳ | 166(24.74) | 31(28.70) |
未知 | 187(27.87) | 31(28.70) |
T分期 | ||
T0 | 2(0.30) | 1(0.93) |
T1 | 92(13.71) | 12(11.11) |
T2 | 27(4.02) | 5(4.63) |
T3 | 166(24.74) | 28(25.93) |
T4 | 136(20.27) | 23(21.30) |
Tx | 248(36.96) | 39(36.11) |
N分期 | ||
N0 | 237(35.32) | 33(30.56) |
N1 | 243(36.21) | 38(35.19) |
N2 | 83(12.37) | 18(16.67) |
Nx | 108(16.10) | 19(17.59) |
M分期 | ||
M1a | 89(13.26) | 19(17.59) |
M1b | 521(77.65) | 79(73.15) |
M1x | 61(9.09) | 10(9.26) |
手术情况 | ||
否 | 546(81.37) | 88(81.48) |
是 | 125(18.63) | 20(18.52) |
淋巴结转移情况 | ||
否 | 576(85.84) | 92(85.19) |
是 | 95(14.16) | 16(14.81) |
脑转移情况 | ||
否 | 646(96.27) | 105(97.22) |
是 | 25(3.73) | 3(2.78) |
肝转移情况 | ||
否 | 239(35.62) | 38(35.19) |
是 | 432(64.38) | 70(64.81) |
肺转移情况 | ||
否 | 381(56.78) | 67(62.04) |
是 | 290(43.22) | 41(37.96) |
放疗情况 | ||
否 | 599(89.27) | 98(90.74) |
是 | 72(10.73) | 10(9.26) |
化疗情况 | ||
否 | 179(26.68) | 23(21.30) |
是 | 492(73.32) | 85(78.70) |
[1] |
Mei XL, Zheng QF. Role of cellular biomolecules in screening, diagnosis and treatment of colorectal cancer[J]. Curr Drug Metab, 2019, 20(11):880-888.
doi: 10.2174/1389200220666191018153428 URL |
[2] |
Sun Y, Wu X, Zhang Y, et al. Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: Incidence, metastatic pattern, and risk factors[J]. Eur J Surg Oncol, 2019, 45(7):1225-1231.
doi: 10.1016/j.ejso.2019.03.005 URL |
[3] |
Guan X, Ma CX, Quan JC, et al. A clinical model to predict the risk of synchronous bone metastasis in newly diagnosed colorectal cancer: A population-based study[J]. BMC Cancer, 2019, 19(1):704.
doi: 10.1186/s12885-019-5912-x pmid: 31315606 |
[4] | Chu GC, Chung L, Gururajan M, et al. Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics[J]. Asian J Urol, 2019, 6(1):65-81. |
[5] | 李明, 谢凤, 张楠, 等. 结直肠癌骨转移的临床特点及治疗(附104例)[J]. 现代肿瘤医学, 2017, 25(14):2276-2280. |
[6] |
Lee SH, Lee JL, Kim CW, et al. Oncologic significance of para-aortic lymph node and inferior mesenteric lymph node metastasis in sigmoid and rectal adenocarcinoma[J]. Eur J Surg Oncol, 2017, 43(11):2076-2083.
doi: 10.1016/j.ejso.2017.08.014 URL |
[7] | 程志远, 王俊男, 闫枫尚, 等. 结直肠癌肺转移患者临床特征及预后影响因素分析——基于SEER数据库的回顾性研究[J]. 中华结直肠疾病电子杂志, 2019, 8(3):251-256. |
[8] |
Sundermeyer ML, Meropol NJ, Rogatko A, et al. Changing patterns of bone and brain metastases in patients with colorectal cancer[J]. Clin Colorectal Cancer, 2005, 5(2):108-113.
doi: 10.3816/CCC.2005.n.022 URL |
[9] |
Ge H, Yan Y, Xie M, et al. Construction of a nomogram to predict overall survival for patients with M1 stage of colorectal cancer: A retrospective cohort study[J]. Int J Surg, 2019, 72:96-101.
doi: 10.1016/j.ijsu.2019.10.021 URL |
[10] | Colorectal Oncology Committee of Chinese Medical Doctor Association. Chinese expert consensus on multidisciplinary treatment of bone metastasis from colorectal cancer (2020 version)[J]. Zhonghua Zhong Liu Za Zhi, 2020, 42(6):433-437. |
[11] |
Benevento I, DE Felice F, Bulzonetti N, et al. Successful treatment of anal canal cancer metastasis to the cranial bones: A case report and literature review[J]. In Vivo, 2019, 33(4):1347-1353.
doi: 10.21873/invivo.11610 pmid: 31280229 |
[12] | 李昂, 谭震, 傅传刚, 等. 结直肠癌根治术后5年内骨转移的危险因素分析[J]. 中华胃肠外科杂志, 2017, 20(1):58-61. |
[13] |
Riihimäki M, Hemminki A, Sundquist J, et al. Patterns of metastasis in colon and rectal cancer[J]. Sci Rep, 2016, 6:29765.
doi: 10.1038/srep29765 pmid: 27416752 |
[14] |
Han L, Dai W, Mo S, et al. Nomogram to predict the risk and survival of synchronous bone metastasis in colorectal cancer: A population-based real-world analysis[J]. Int J Colorectal Dis, 2020, 35(8):1575-1585.
doi: 10.1007/s00384-020-03612-z URL |
[15] |
Li J, Gu J, Ma X, et al. Development and validation of a nomogram for predicting survival in Chinese han patients with resected colorectal cancer[J]. J Surg Oncol, 2018, 118(6):1034-1041.
doi: 10.1002/jso.25213 URL |
[16] |
Karagkounis G, Kalady MF. Molecular biology: Are we getting any closer to providing clinically useful information?[J]. Clin Colon Rectal Surg, 2017, 30(5):415-422.
doi: 10.1055/s-0037-1606373 URL |
[17] |
Tanabe T, Shida D, Tsukamoto S, et al. Metachronous metastasis to inguinal lymph nodes from sigmoid colon adenocarcinoma with abdominal wall metastasis: A case report[J]. BMC Cancer, 2019, 19(1):180.
doi: 10.1186/s12885-019-5386-x pmid: 30813921 |
[18] | Ouyang GL, Meng WJ, Shu P, et al. Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2019, 22(4):349-356. |
[19] |
Huang MY, Huang CW, Wang JY. Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer[J]. Kaohsiung J Med Sci, 2020, 36(3):152-159.
doi: 10.1002/kjm2.v36.3 URL |
[20] | Xie P, Mo JL, Liu JH, et al. Pharmacogenomics of 5-fluorouracil in colorectal cancer: Review and update[J]. Cell Oncol (Dordr), 2020, 43(16):989-1001. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||